Latest News about REGN
Recent news which mentions REGN
Regeneron Reveals Updated Data From Multiple Myeloma Study, Showing Response Rate Of 71%
May 26, 2023
Tickers
REGN
From Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
May 22, 2023
Tickers
REGN
From Benzinga
From Benzinga
From InvestorPlace
AI-Run ETF Dumps Apple In Favor Of This Chip Stock And Hints At New Opportunity Brewing In Market
May 12, 2023
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
Alnylam - Regeneron Partnered Alzheimer's Candidate's Initial Data Sounds Promising, Analyst Says
April 27, 2023
From Benzinga
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
From Benzinga
Unity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eylea
April 24, 2023
From Benzinga
The Greatest 7 Blue-Chip Stocks to Buy for Your Portfolio
April 20, 2023
From InvestorPlace
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 5 Years
April 18, 2023
Tickers
REGN
From Benzinga
MAIA Biotechnology Touts Positive Data From Healthy Volunteer Study Of Potential Lung Cancer Candidate
April 11, 2023
From Benzinga
Investing $1,000 In These 2 Top Stocks Would Be a Great Move
April 09, 2023
From Motley Fool
2 Top Growth Stocks That Could Soar This Spring
April 06, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.